Microsoft word - folleto preliminar euroataxia. pilar-patrocinadores

SCIENTIFIC PROGRAMME: 25 th September 2009.
of Molecular Biology Severo Ochoa. University Autónoma of ˜ Announce the actual state in the investigation of recessive 08,45-09,00 Data collection.
Madrid. "Human neuronal cell models and gene therapy and dominant ataxias in Europe and all over the world" ˜ Keep in touch those Scientifics who work with ataxias in 09.00 - 09.30 OFICIAL INAUGURATION
12.30-12.50 Dr. Salvador Martínez Pérez. Institute of
Europe with specialists who can organize medical trials". Welcome:
Neurosciences. University Miguel Hernández. Campus de San ˜ Incorporate researchers and doctors (with great experience in Joan. Alicante. "Celular therapy on ataxia: Possibilities of different areas of investigation) into different investigation Isabel Campos. Deputy chairwoman of Fedaes.
"Presentation video of FEDAES"
Discussion on results facilitated by Dr. Francesc Palau
Francesc Palau: Deputy chairman of Euroataxia.
˜ Show the advances of the different groups and set up new "Director of CIBER of rare diseases, Valencia- National
13.30-15.00 lunch.
"Plan strategies to the recovery of patients". strategy on rare diseases"
"Establish colaboratation strategies among all European 15.10-17.00 Session II - General Investigation on dominant
09,30-13,30 Session I - General investigation on recessive
˜ Spread scientific advances in ataxia among researchers and members of European and north American associations". 15.10-15.30 Dr. David Genís. Servicio de neurología. General
09.30-09.50 Dr. Massimo Pandolfo. (Hôpital Erasme-
˜ Establish collaboration mechanisms to apply for the financial Hospital of Gerona. Spain. "Current state of the investigation support of the VII Marco Program of investigation". Université Libre de Bruxelles, Belgium) "Current state of histone deacetylase inhibitors investigation''. 15.30-15.50 Dr. Antoni Matilla Dueñas. Investigator in
09.50-10,10 Dr. José Vicente Llorens Department of
Neurosciences of the Spanish National Health System - Current state of the study about histones deacetilases Genetics. University of Biology. University of Valencia. Coordinator of Basic Research in Ataxias and "Drosophila and frataxin: effects of its reduction and Neurodegenerative diseases. Neurosciences Department and -Growth factor IGF-1. Study on animal models-Biochemical Neurology Service Health Sciences Research Institute 10.10-10.30 Dra. Daniele Marmolino. Laboratoire de
Germans Trias i Pujol (IGTP) Autonomous University of Neurologie Expérimentale, Hôpital Erasme, Université Libre Barcelona. "Spinocerebellar ataxia type 1 (SCA1): molecular de Bruxelles (ULB), Brussels, Belgium. "PPAR-gamma pathways, pathogenic mechanisms, and therapy." -Gamma receptor agonist in Friedrich's ataxia Agonist Azelaoyl PAF Increases Frataxin Protein and 15.50-16.10 Dr. Luís Pereira de Almeida. Faculty of
-Clinical trials with: Idebenone, Riboflavine, EPO, IGF-1, mRNA.expression. New Implications for the Friedreich's Pharmacy & Center for Neurosciences and Cell Biology University of Coimbra. Portugal "RNA interference on SCA- 10.30-10.50 Dr. Ignacio Torres Alemán: Laboratory of
Neuroendocrinology. (Institute Cajal. CSIC. Madrid) SUBJECTS: Neurologists, neuro-pediatricians, researchers
16.10-16.30 Dr. Manuel Álvarez Dolado. Savilla. "Cell
and management members of European ataxia associations. " Response of Friedreich ataxia murine models to the IGF-1 " Therapy in a Mosuse Model Purkinje Cell Degeneration, o 10.50-11.10 Dr. Isaac Amela Abellán. Laboratory of
Bioinformatics Institute of Biotechnology and Biomedicine PARTICIPANTS: 80 persons.
Discussion on results facilitated by Dra. Mercedes Pineda.
(IBB) Universitat Autònoma de Barcelona "Friedreich Ataxia, computacional dynamic Model of the proteins that form the CONFERENCE ORGANIZATION:
Sesión III - Clinical Trials
complex Iron - sulphur in Saccharomyces cerevisiae" 11.10 - 11.30h: Coffee break
17.00-17.20 Dr. Francisco Javier Arpa. Department of
DATE: 25 th and 26 th september 2009.
Neurology. Hospital La Paz.- Madrid. "Clinical trials in 11.30-11.50 Dr. Dr. Juan Antonio Navarro. Universität
Regensburg. Germany."Altered lipid metabolism in a adults with Deferriprone, idebenone, Riboflavin, IGF-1" TIMETABLE: established in the programme.
17.20-17.40 Dr. José Luis Muñoz. Servicio de Neurología.
Drosophila model of Friedreich Ataxia" Hospital Gregorio Marañón. Madrid. "Clinical trials with GH 11.50-12.10 Javier Diaz Nido. Departament of Molecular
PLACE: Hotel Meliá Olid. Plaza San Miguel, nº 10.
Biology. Centre of Molecular Biology "Severo Ochoa" 17.40-18.00 Dra.Mercedes Pineda Marfá y Dra. Asunción
(CSIC-UAM). University Autonoma of Madrid. Aracil. Neuropediatrics. Hospital San Joan de Deu. Barcelona.
"Knock-down of frataxin gene expression in human neuron- "Ataxia with Co Q deficiency in children". like cells as a cell model for Friedreich's ataxia". 12.10-12.30 Dr. Filip Lim. Faculty of sciences. Department
18.00-18.30 Coffee break
18.30-18.50 Dr. Rafael Artuch Iriberri.
Hospital Sant Joan de Deu. Department of clinical
biochemistry. "Friedreich ataxia's patients Monitorship"
18.50-19.10 Dr. Giuseppe De Michele. Dipartimento di Scienze Neurologiche Università
Federico II. Nápoles. Italia. "New therapeutic strategies for hereditary ataxias, in particular our
results on erythropoietin"
19.10-19.30 Dr. Pierre Rustin Hopital Robert Debre, Paris. Francia. "Pioglitazone in FRDA: Why
and How?
19.30-19.50 Dra. Benedicta Catalán. Hospital Universitario de Valladolid. "Results of the
clinical trials with Fosfatil-B vitamin complex"
19.50-20.10 TAKEDA. "Results of the multicentric clinical trial with idebenone".WAITING FOR

Discussion on results facilitated by Dr. Antoni Matilla

21.30h: Dinner
ASSOCIATIONS PROGRAMME: 26 th september 2009.
10.00-13.00 Session IV. Interventions of patient's associations
-¿What activities could we develop to achieve european financing? -Meeting of the steering committee of Euroataxia. SOCIAL PROGRAMME:

From 10.00 to 13.00 we will organize a touristic tour going round all the emblematic places
of Valladolid. (It will be to the participants who haven't to take part in Session IV)
The participants who (have filled) the booking form, shall remove the conference documentation from Friday 25th september, 08.45h, in the place conference will take part. For any further information about the programme and the social work of FEDAES in: Sponsorship:


Microsoft word - material safety data sheet -2,4 dbc.doc

Material Safety Data Sheet 2,4 - DICHLORO BENZOYL CHLORIDE Section 1 - Product and Company Information : 2,4 – Dichloro Benzoyl Chloride, DCOC Section 2 - Composition / Information on Ingredients Product Name Mol. Formula Mol. Weight. Section 3 – Hazards Identification SPECIAL INDICATION OF HAZARDS TO HUMANS AND THE ENVIROMENT HAZARD DISCRIPTION

Microsoft word - harrassment policy.procedure.spanish.docx

Code: JFCF/GBNA-AR Novatadas/Acoso/Intimidación/Intimidar/Amenazas Ciberintimidación - Estudiantes/Personal/Terceros Las definiciones siguientes y los procedimientos serán usadas para la denuncia, la investigación y la resolución de quejas de novatada, acoso, intimidación, comportamiento abusador, y actos de ciberintimidacion y amenazas. Definiciones 1. "Los tercero

Copyright © 2018 Predicting Disease Pdf